We are live on ! Find out more
DCM

DAFNA Capital Management Portfolio holdings

AUM $440M
1-Year Est. Return 109.12%
This Fund
S&P 500
This Quarter Est. Return
-9.1%
1 Year Est. Return
+109.12%
3 Year Est. Return
+239.59%
5 Year Est. Return
+227.89%
10 Year Est. Return
+3,611.91%
AUM
$377M
AUM Growth
-$101M
Cap. Flow
-$18.7M
Cap. Flow %
-4.96%
Top 10 Hldgs %
50.73%
Holding
91
New
7
Increased
20
Reduced
15
Closed
11

Top Buys

1
CYTK icon
Cytokinetics
CYTK
+$5.15M
2
ALEC icon
Alector
ALEC
+$3.01M
3
IDYA icon
IDEAYA Biosciences
IDYA
+$3M
4
KALV
KalVista Pharmaceuticals
KALV
+$2.61M
5
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
+$2.49M

Top Sells

1
TBPH icon
Theravance Biopharma
TBPH
+$10.6M
2
TBIO
Translate Bio, Inc. Common Stock
TBIO
+$10.4M
3
LMNX
Luminex Corp
LMNX
+$5.12M
4
PRQR icon
ProQR Therapeutics
PRQR
+$4.81M
5
TVRD
Tvardi Therapeutics
TVRD
+$4.5M

Sector Composition

1 Healthcare 91.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
STXS icon
1
Stereotaxis
STXS
$161M
$73.6M 19.53%
13,680,554
– –
BPMC
2
DELISTED
Blueprint Medicines
BPMC
$21.3M 5.64%
206,911
-1,000
-0.5% -$93.1K
FATE icon
3
Fate Therapeutics
FATE
$349M
$20.4M 5.41%
344,360
+30,000
+10% +$2.35M
BHVN
4
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$12.2M 3.25%
88,100
-6,000
-6% -$749K
DRNA
5
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$11.8M 3.14%
587,456
+76,700
+15% +$2.12M
IDYA icon
6
IDEAYA Biosciences
IDYA
$3.54B
$11.7M 3.11%
460,061
+128,400
+39% +$3M
DXCM icon
7
DexCom
DXCM
$28.1B
$11.6M 3.07%
84,552
– –
MORF
8
DELISTED
Morphic Holding, Inc. Common Stock
MORF
$10.3M 2.73%
181,467
– –
NRIX icon
9
Nurix Therapeutics
NRIX
$2.48B
$9.18M 2.43%
306,320
– –
KRTX
10
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$9.12M 2.42%
74,585
+21,585
+41% +$2.49M
NBIX icon
11
Neurocrine Biosciences
NBIX
$17.3B
$8.12M 2.15%
84,655
+11,000
+15% +$1.04M
SAGE
12
DELISTED
Sage Therapeutics
SAGE
$7.99M 2.12%
180,306
+10,000
+6% +$459K
ARNA
13
DELISTED
Arena Pharmaceuticals Inc
ARNA
$7.12M 1.89%
119,615
– –
IBB icon
14
iShares Biotechnology ETF
IBB
$9.24B
$6.61M 1.75%
40,900
– –
CSII
15
DELISTED
Cardiovascular Systems, Inc.
CSII
$6.36M 1.69%
193,741
+44,041
+29% +$1.64M
CYTK icon
16
Cytokinetics
CYTK
$11.2B
$6.25M 1.66%
+175,000
New +$5.15M
XENE icon
17
Xenon Pharmaceuticals
XENE
$6.55B
$6.21M 1.65%
406,535
– –
AFMD
18
DELISTED
Affimed
AFMD
$5.96M 1.58%
96,486
– –
RVMD icon
19
Revolution Medicines
RVMD
$39.2B
$5.77M 1.53%
209,731
– –
FSTX
20
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
$5.08M 1.35%
693,785
-20,500
-3% -$141K
ATRC icon
21
AtriCure
ATRC
$1.75B
$5.01M 1.33%
72,029
-19,500
-21% -$1.5M
OTIC
22
DELISTED
Otonomy, Inc.
OTIC
$4.57M 1.21%
2,379,392
– –
RCUS icon
23
Arcus Biosciences
RCUS
$3.52B
$4.31M 1.14%
123,700
+4,000
+3% +$124K
LKFT
24
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.93B
$4.09M 1.08%
77,675
– –
ARAY icon
25
Accuray
ARAY
$32.7M
$3.72M 0.99%
941,800
– –
1
2 3 4

Similar funds

FGWP
Founders Grove Wealth Partners Richmond, Virginia $440M AUM 16.56% 1-Year Est. Return
STCG
Speece Thorson Capital Group Minnetonka, Minnesota $439M AUM 10.15% 1-Year Est. Return
SCP
SailingStone Capital Partners Houston, Texas $440M AUM 127.21% 1-Year Est. Return
CAAM
Cape Ann Asset Management London, United Kingdom $440M AUM 96.23% 1-Year Est. Return
AWM
Austin Wealth Management Austin, Texas $440M AUM 17.66% 1-Year Est. Return
HCM
Harvey Capital Management Palm Beach, Florida $439M AUM 37.68% 1-Year Est. Return
CPW
Cove Private Wealth Oyster Bay Cove, New York $440M AUM 27.56% 1-Year Est. Return
DWML
Decker Wealth Management LLC Nashville, Tennessee $440M AUM